甘肃地区1 159例苯丙酮尿症患儿基因型与干预策略分析

张钏, 张培, 周秉博, 王兴, 郑雷, 李修晶, 郭金仙, 陈丕亮, 惠玲, 达振强, 闫有圣

中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (7) : 808-814.

PDF(632 KB)
HTML
PDF(632 KB)
HTML
中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (7) : 808-814. DOI: 10.7499/j.issn.1008-8830.2502040
论著·临床研究

甘肃地区1 159例苯丙酮尿症患儿基因型与干预策略分析

作者信息 +

Genetic profiling and intervention strategies for phenylketonuria in Gansu, China: an analysis of 1 159 cases

Author information +
文章历史 +

摘要

目的 对甘肃地区苯丙酮尿症(phenylketonuria, PKU)患儿进行分子流行病学调查,以期为PKU的干预策略提供基础性数据。 方法 回顾性收集2012年1月—2024年12月甘肃省妇幼保健院就诊的1 159个PKU患儿家系,通过Sanger测序、多重连接依赖探针扩增技术、全外显子组测序以及深部内含子变异分析对PAH基因进行分析。 结果 1 159例PKU患儿中,患儿的2 318个等位基因中检测到2 295个变异,检出率为99.01%。其中457个经典型PKU患儿家系检出率为100%(914/914),456个轻度PKU患儿家系检出率为99.45%(907/912),246个轻度高苯丙氨酸血症患儿家系检出率为96.34%(474/492)。检测到的2 295个等位基因变异分属于208种变异,其中出现频率最高的是c.728G>A(14.95%,343/2 295),其次为c.611A>G(4.88%,112/2 295),随后为c.721C>T(4.79%,110/2 295)。前23位热点变异的累计频率达70.28%(1 613/2 295)。外显子7上检测到的变异等位最多(29.19%,670/2 295)。 结论PAH基因进行深部内含子变异分析,可以进一步提高PKU基因诊断率。针对PAH基因热点变异位点与区域设计研发相应检测试剂盒可能有助于PKU的精准筛查与防控。

Abstract

Objective To investigate the molecular epidemiology of children with phenylketonuria (PKU) in Gansu, China, providing foundational data for intervention strategies. Methods A retrospective analysis was conducted on 1 159 PKU families who attended Gansu Provincial Maternity and Child Care Hospital from January 2012 to December 2024. Sanger sequencing, multiplex ligation-dependent probe amplification, whole exome sequencing, and deep intronic variant analysis were used to analyze the PAH gene. Results For the 1 159 children with PKU, 2 295 variants were identified in 2 318 alleles, resulting in a detection rate of 99.01%. The detection rates were 100% (914/914) in 457 classic PKU families, 99.45% (907/912) in 456 mild PKU families, and 96.34% (474/492) in 246 mild hyperphenylalaninemia families. The 2 295 variants detected comprised 208 distinct mutation types, among which c.728G>A (14.95%, 343/2 295) had the highest frequency, followed by c.611A>G (4.88%, 112/2 295) and c.721C>T (4.79%, 110/2 295). The cumulative frequency of the top 23 hotspot variants reached 70.28% (1 613/2 295), and most variant alleles were detected in exon 7 (29.19%, 670/2 295). Conclusions Deep intronic variant analysis of the PAH gene can improve the genetic diagnostic rate of PKU. The development of targeted detection kits for PAH hotspot variants may enable precision screening programs and enhance preventive strategies for PKU.

关键词

苯丙酮尿症 / 基因诊断 / 基因变异 / 深部内含子 / 精准筛查 / 儿童

Key words

Phenylketonuria / Genetic diagnosis / Gene variant / Deep intronic variant analysis / Precision screening / Child

引用本文

导出引用
张钏, 张培, 周秉博, . 甘肃地区1 159例苯丙酮尿症患儿基因型与干预策略分析[J]. 中国当代儿科杂志. 2025, 27(7): 808-814 https://doi.org/10.7499/j.issn.1008-8830.2502040
Chuan ZHANG, Pei ZHANG, Bing-Bo ZHOU, et al. Genetic profiling and intervention strategies for phenylketonuria in Gansu, China: an analysis of 1 159 cases[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(7): 808-814 https://doi.org/10.7499/j.issn.1008-8830.2502040

参考文献

[1]
Hillert A, Anikster Y, Belanger-Quintana A, et al. The genetic landscape and epidemiology of phenylketonuria[J]. Am J Hum Genet, 2020, 107(2): 234-250. PMCID: PMC7413859. DOI: 10.1016/j.ajhg.2020.06.006 .
[2]
Scriver CR. The PAH gene, phenylketonuria, and a paradigm shift[J]. Hum Mutat, 2007, 28(9): 831-845. DOI: 10.1002/humu.20526 .
[3]
Guldberg P, Henriksen KF, Sipilä I, et al. Phenylketonuria in a low incidence population: molecular characterisation of mutations in Finland[J]. J Med Genet, 1995, 32(12): 976-978. PMCID: PMC1051781. DOI: 10.1136/jmg.32.12.976 .
[4]
Gundorova P, Zinchenko RA, Kuznetsova IA, et al. Molecular-genetic causes for the high frequency of phenylketonuria in the population from the North Caucasus[J]. PLoS One, 2018, 13(8): e0201489. PMCID: PMC6070269. DOI: 10.1371/journal.pone.0201489 .
[5]
Okano Y, Hase Y, Lee DH, et al. Frequency and distribution of phenylketonuric mutations in Orientals[J]. Hum Mutat, 1992, 1(3): 216-220. DOI: 10.1002/humu.1380010307 .
[6]
Sutivijit Y, Banpavichit A, Wiwanitkit V. Prevalence of neonatal hypothyroidism and phenylketonuria in Southern Thailand: a 10-year report[J]. Indian J Endocrinol Metab, 2011, 15(2): 115-117. PMCID: PMC3124997. DOI: 10.4103/2230-8210.81941 .
[7]
Xiang L, Tao J, Deng K, et al. Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: a descriptive study[J]. BMJ Open, 2019, 9(8): e031474. PMCID: PMC6707664. DOI: 10.1136/bmjopen-2019-031474 .
[8]
张钏, 惠玲, 周秉博, 等. 甘肃地区遗传代谢病疾病谱及致病基因分析[J]. 中国当代儿科杂志, 2024, 26(1): 67-71. PMCID: PMC10817745. DOI: 10.7499/j.issn.1008-8830.2308094 .
[9]
张钏, 郝胜菊, 王晓黎, 等. 55个苯丙酮尿症家系产前诊断与基因突变分析[J]. 中华围产医学杂志, 2018, 21(11): 764-768. DOI: 10.3760/cma.j.issn.1007-9408.2018.11.009 .
[10]
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30 .
[11]
Zhang C, Zhang P, Yan Y, et al. The spectrum of phenylalanine hydroxylase variants and genotype-phenotype correlation in phenylketonuria patients in Gansu, China[J]. Hum Genomics, 2023, 17(1): 36. PMCID: PMC10127316. DOI: 10.1186/s40246-023-00475-7 .
[12]
Zschocke J. Phenylketonuria mutations in Europe[J]. Hum Mutat, 2003, 21(4): 345-356. DOI: 10.1002/humu.10192 .
[13]
Aulehla-Scholz C, Heilbronner H. Mutational spectrum in German patients with phenylalanine hydroxylase deficiency[J]. Hum Mutat, 2003, 21(4): 399-400. DOI: 10.1002/humu.9116 .
[14]
Kostandyan N, Britschgi C, Matevosyan A, et al. The spectrum of phenylketonuria genotypes in the Armenian population: identification of three novel mutant PAH alleles[J]. Mol Genet Metab, 2011, 104 Suppl: S93-S96. DOI: 10.1016/j.ymgme.2011.08.006 .
[15]
Li N, Jia H, Liu Z, et al. Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing[J]. Sci Rep, 2015, 5: 15769. PMCID: PMC4621502. DOI: 10.1038/srep15769 .
[16]
Wang R, Shen N, Ye J, et al. Mutation spectrum of hyperphenylalaninemia candidate genes and the genotype-phenotype correlation in the Chinese population[J]. Clin Chim Acta, 2018, 481: 132-138. DOI: 10.1016/j.cca.2018.02.035 .
[17]
Martínez-Pizarro A, Dembic M, Pérez B, et al. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site[J]. PLoS Genet, 2018, 14(4): e1007360. PMCID: PMC5933811. DOI: 10.1371/journal.pgen.1007360 .
[18]
Bercovich D, Elimelech A, Zlotogora J, et al. Genotype-phenotype correlations analysis of mutations in the phenylalanine hydroxylase (PAH) gene[J]. J Hum Genet, 2008, 53(5): 407-418. DOI: 10.1007/s10038-008-0264-4 .
[19]
赵德华, 李晓乐, 贾晨路, 等. 河南地区苯丙氨酸羟化酶缺乏症基因突变型与表型的关系研究[J]. 中华医学遗传学杂志, 2016, 33(3): 300-305. DOI: 10.3760/cma.j.issn.1003-9406.2016.03.005 .
[20]
Bashyam MD, Chaudhary AK, Kiran M, et al. Splice, insertion-deletion and nonsense mutations that perturb the phenylalanine hydroxylase transcript cause phenylketonuria in India[J]. J Cell Biochem, 2014, 115(3): 566-574. DOI: 10.1002/jcb.24692 .
[21]
Lee YW, Lee DH, Kim ND, et al. Mutation analysis of PAH gene and characterization of a recurrent deletion mutation in Korean patients with phenylketonuria[J]. Exp Mol Med, 2008, 40(5): 533-540. PMCID: PMC2679362. DOI: 10.3858/emm.2008.40.5.533 .
[22]
Okano Y, Kudo S, Nishi Y, et al. Molecular characterization of phenylketonuria and tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Japan[J]. J Hum Genet, 2011, 56(4): 306-312. DOI: 10.1038/jhg.2011.10 .
[23]
Xiao Y, Gu Q, Wu HR, et al. Molecular diagnosis of phenylketonuria in 157 Chinese families and the results of prenatal diagnosis in these families[J]. Chin Med J (Engl), 2021, 134(13): 1626-1628. PMCID: PMC8280003. DOI: 10.1097/CM9.0000000000001469 .
[24]
陈晨, 赵振华, 任依琳, 等. 河南地区113例苯丙酮尿症患者PAH基因的变异特点[J]. 中华医学遗传学杂志, 2018, 35(6): 791-795. DOI: 10.3760/cma.j.issn.1003-9406.2018.06.003 .
[25]
陆清, 刘艳秋, 杨必成, 等. 苯丙酮尿症患者苯丙氨酸羟化酶基因的变异研究[J]. 中华医学遗传学杂志, 2019, 36(11): 1057-1061. DOI: 10.3760/cma.j.issn.1003-9406.2019.11.001 .

脚注

所有作者均声明不存在利益冲突。

基金

北京市自然科学基金(7232062)
甘肃省卫生健康行业科技创新重大科研项目(GSWSQNPY2025-19)
甘肃省科技计划资助项目(22YF7FA094)
医院科研基金项目资助项目(GMCCH2024-2-2)
医院科研基金项目资助项目(GMCCH2025-2-3-08)
甘肃省卫生行业计划项目(GSWSKY2022-33)
甘肃省科技厅创新基地及人才计划(21JR7RA680)
甘肃省自然科学基金(1606RJZA151)

编委: 王颖

版权

版权所有 © 2023中国当代儿科杂志
PDF(632 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/